Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance

Background: The rate of contralateral risk-reducing mastectomy (CRRM) is increasing in the West with controversial evidence of improved survival in early breast cancer patients. Although uptake of CRRM in Asia appears low, the trends may rise, and there is currently an urgent need to provide evidenc...

Full description

Saved in:
Bibliographic Details
Main Authors: See, Mee Hoong, Bhoo-Pathy, Nirmala, Jamaris, Suniza, Kiran, A., Evans, Dafydd Gareth, Yip, Cheng Har, Mohd Taib, Nur Aishah
Format: Article
Published: Springer Verlag (Germany) 2018
Subjects:
Online Access:http://eprints.um.edu.my/20754/
https://doi.org/10.1007/s00268-017-4319-6
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.20754
record_format eprints
spelling my.um.eprints.207542019-03-19T04:51:11Z http://eprints.um.edu.my/20754/ Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance See, Mee Hoong Bhoo-Pathy, Nirmala Jamaris, Suniza Kiran, A. Evans, Dafydd Gareth Yip, Cheng Har Mohd Taib, Nur Aishah R Medicine Background: The rate of contralateral risk-reducing mastectomy (CRRM) is increasing in the West with controversial evidence of improved survival in early breast cancer patients. Although uptake of CRRM in Asia appears low, the trends may rise, and there is currently an urgent need to provide evidence for informed decision-making in clinical practice. This study aims to determine the risk of contralateral breast cancer (CBC) and its associated factors in an Asian setting. Method: A total of 2937 newly diagnosed patients with stage I and stage II breast cancer in University Malaya Medical Centre between Jan 1993 to Dec 2012 were included in the study. Multinomial logistic regression analysis allowing death to compete with CBC as a study outcome was used; patients with unilateral breast cancer who were alive were taken as reference. A stepwise backward regression analysis including age at diagnosis, ethnicity, family history of breast cancer, TNM stage, hormonal receptor status, HER2 status, chemotherapy, radiotherapy, and hormone therapy was conducted. Results: Fifty women developed CBC, over a median follow-up of 6 years. The 5- and 10-year cumulative risk of contralateral breast cancer was 1.0% (95% CI 0.6–1.4%) and 2.8% (95% CI 2.0–3.6%), respectively. Young age at diagnosis of first cancer, positive family history, and stage I disease were independent predictors of CBC. Discussion: The current study suggests that the risk of CBC is very low in a Southeast Asian setting. Any recommendations or practice of CRRM should be reviewed with caution and patients must be counseled appropriately. Springer Verlag (Germany) 2018 Article PeerReviewed See, Mee Hoong and Bhoo-Pathy, Nirmala and Jamaris, Suniza and Kiran, A. and Evans, Dafydd Gareth and Yip, Cheng Har and Mohd Taib, Nur Aishah (2018) Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance. World Journal of Surgery, 42 (5). pp. 1270-1277. ISSN 0364-2313 https://doi.org/10.1007/s00268-017-4319-6 doi:10.1007/s00268-017-4319-6
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine
spellingShingle R Medicine
See, Mee Hoong
Bhoo-Pathy, Nirmala
Jamaris, Suniza
Kiran, A.
Evans, Dafydd Gareth
Yip, Cheng Har
Mohd Taib, Nur Aishah
Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
description Background: The rate of contralateral risk-reducing mastectomy (CRRM) is increasing in the West with controversial evidence of improved survival in early breast cancer patients. Although uptake of CRRM in Asia appears low, the trends may rise, and there is currently an urgent need to provide evidence for informed decision-making in clinical practice. This study aims to determine the risk of contralateral breast cancer (CBC) and its associated factors in an Asian setting. Method: A total of 2937 newly diagnosed patients with stage I and stage II breast cancer in University Malaya Medical Centre between Jan 1993 to Dec 2012 were included in the study. Multinomial logistic regression analysis allowing death to compete with CBC as a study outcome was used; patients with unilateral breast cancer who were alive were taken as reference. A stepwise backward regression analysis including age at diagnosis, ethnicity, family history of breast cancer, TNM stage, hormonal receptor status, HER2 status, chemotherapy, radiotherapy, and hormone therapy was conducted. Results: Fifty women developed CBC, over a median follow-up of 6 years. The 5- and 10-year cumulative risk of contralateral breast cancer was 1.0% (95% CI 0.6–1.4%) and 2.8% (95% CI 2.0–3.6%), respectively. Young age at diagnosis of first cancer, positive family history, and stage I disease were independent predictors of CBC. Discussion: The current study suggests that the risk of CBC is very low in a Southeast Asian setting. Any recommendations or practice of CRRM should be reviewed with caution and patients must be counseled appropriately.
format Article
author See, Mee Hoong
Bhoo-Pathy, Nirmala
Jamaris, Suniza
Kiran, A.
Evans, Dafydd Gareth
Yip, Cheng Har
Mohd Taib, Nur Aishah
author_facet See, Mee Hoong
Bhoo-Pathy, Nirmala
Jamaris, Suniza
Kiran, A.
Evans, Dafydd Gareth
Yip, Cheng Har
Mohd Taib, Nur Aishah
author_sort See, Mee Hoong
title Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
title_short Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
title_full Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
title_fullStr Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
title_full_unstemmed Low Lifetime Risk of Contralateral Breast Cancer in a Middle-Income Asian Country: Evidence to Guide Post-treatment Surveillance
title_sort low lifetime risk of contralateral breast cancer in a middle-income asian country: evidence to guide post-treatment surveillance
publisher Springer Verlag (Germany)
publishDate 2018
url http://eprints.um.edu.my/20754/
https://doi.org/10.1007/s00268-017-4319-6
_version_ 1643691370339106816
score 13.188404